Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Lanxess
(OTCPK:LNXSF)
Intraday
$28.12
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$28.12
0
[0.00%]
Last update: 1:53PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Lanxess Stock (OTC:LNXSF)
Lanxess Stock (OTC: LNXSF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 15, 2021
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
Benzinga Insights
-
Sep 15, 2021, 10:05AM
Credit Suisse Upgrades Lanxess to Outperform
Benzinga Newsdesk
-
Sep 15, 2021, 5:06AM
Thursday, August 19, 2021
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
Benzinga Insights
-
Aug 19, 2021, 10:10AM
Goldman Sachs Upgrades Lanxess to Buy
Benzinga Newsdesk
-
Aug 19, 2021, 5:13AM
Friday, March 05, 2021
Palantir And AWS Team Up For ERP Suite
Melanie Schaffer
-
Mar 5, 2021, 3:50PM
Monday, September 26, 2016
12 Biggest Mid-Day Gainers For Monday
Benzinga
-
Sep 26, 2016, 12:10PM
Benzinga's Volume Movers
Benzinga
-
Sep 26, 2016, 10:42AM
15 Stocks Moving In Monday's Pre-Market Session
Benzinga
-
Sep 26, 2016, 8:30AM
Must Watch Stocks for September 26, 2016
Benzinga
-
Sep 26, 2016, 5:12AM
Chemtura Trading at $32.94 in Premarket +16.9%; Being Acquired by Lanxess for $33.50/Share
Benzinga
-
Sep 26, 2016, 5:03AM
Sunday, September 25, 2016
Benzinga's Weekend M&A Chatter
Benzinga
-
Sep 25, 2016, 9:03PM
UPDATE: Chemtura to Be Acquired by LANXESS for ~$2.5B in All-Cash Transaction; $33.50/Share
Benzinga
-
Sep 25, 2016, 8:09PM
UPDATE: LANXESS Signs Contract to Acquire Chemtura for $33.50/Share in Cash; Enterprise Value of ~€2.4B
Benzinga
-
Sep 25, 2016, 6:37PM
LANXESS to Acquire Chemtura for $33.50/Share in Cash
Benzinga
-
Sep 25, 2016, 6:33PM
Tuesday, November 06, 2012
Lanxess Q3 Net Profit Down 39%
Benzinga
-
Nov 6, 2012, 4:11AM
Tuesday, August 07, 2012
Lanxess Posts Decline In Q2 Profit
Benzinga
-
Aug 7, 2012, 5:25AM
Wednesday, May 09, 2012
Lanxess Posts Rise In Q1 Profit, Sales
Benzinga
-
May 9, 2012, 5:04AM
Thursday, August 11, 2011
Earnings Roundup
Benzinga
-
Aug 11, 2011, 9:10AM
Lanxess Lifts Full-Year Forecast
Benzinga
-
Aug 11, 2011, 5:01AM